ALAD Inhibition by Porphobilinogen Rationalizes the Accumulation of δ-Aminolevulinate in Acute Porphyrias

Author:

San Juan Itxaso1,Pereira-Ortuzar Tania1,Cendoya Xabier2,Laín Ana1,To-Figueras Jordi3,Mateos Borja1,Planes Francisco J.24,Bernardo-Seisdedos Ganeko15,Mato José M.16,Millet Oscar156ORCID

Affiliation:

1. Precision Medicine and Metabolism Laboratory, CIC bioGUNE, Basque Research and Technology Alliance (BRTA), Bizkaia Science and Technology Park, 48160 Derio, Spain

2. , Universidad de Navarra, Tecnun Escuela de Ingeniería y Centro de Ingeniería Biomédica, San Sebastián 20009, Spain

3. Biochemistry and Molecular Genetics Unit, Hospital Clinic, IDIBAPS, University of Barcelona, Villarroel 170, 08036 Barcelona, Spain

4. Universidad de Navarra, DATAI Instituto de Ciencia de los Datos e Inteligencia Artificial, Pamplona 31009, Spain

5. ATLAS Molecular Pharma, Bizkaia Science and Technology Park, 48160 Derio, Spain

6. Biomedical Research Network on Hepatic and Digestive Diseases (CIBEREHD), Instituto de Salud Carlos III, Madrid 28029, Spain

Funder

Agencia Estatal de Investigaci?n

Eusko Jaurlaritza

Horizon 2020 Framework Programme

National Institutes of Health

European Federation of Pharmaceutical Industries and Associations

Publisher

American Chemical Society (ACS)

Subject

Biochemistry

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3